Expression and correlation of P12-LOX and uPA in human breast cancer

Wen Wang,Shuqun Zhang,Hong Zhang,Tian Tian,Xixi Zhao
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.08.013
2017-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the expression and correlation of platelet-type 12-lipoxygenase(P12-LOX) and urokinase-type plasminogen activator(uPA) in the tissues of breast cancer.Methods:The expression of uPA and P12-LOX protein was detected in 20 cases of benign breast disease,58 cases of non-triple negative breast cancer and 24 cases of triple negative breast cancer by immunohistochemistry,and analyzed the relationship between them and the clinical pathological,and the relationship between uPA and P12-LOX.The expression of P12-LOX and uPA mRNA in three different breast cancer lines with different invasion ability were detected with qRT-PCR.Results:The positive expression rate of uPA and P12-LOX in three different breast cancer tissues were increased gradually with the tumor malignant degree.The difference was significant(P < 0.01).The expression of uPA was positively correlated with the expression of P12-LOX in breast cancer(r =0.512,P < 0.01).The expression of uPA and P12-LOX was significantly correlated with lymphatic metastasis and surgical-pathologic staging(P < 0.01),but not significantly correlated with age and tumor size(P > 0.05).In three different breast cancer lines the expression of P12 -LOX and uPA mRNA increased with the invasion ability (P < 0.01).Conclusion:The overexpression of uPA and P12-LOX is found in breast carcinoma,and associated with the invasion and metastasis of breast cancer,which can be used as indicators of poor prognosis in breast cancer patients.
What problem does this paper attempt to address?